At 48 weeks provisional approval is not justified.
My argument for provisional approval is based on
1) Sleep and GABA data released from subsequent trials. 2) Safety 3) The abysmally low bar set by SOC.
No reason not to expect approval..JMHO.
Neurotrope made huge claims based on compassionate use cases. The trials have not supported these claims. That is my main reason for believing it is a pump and dump.
Market Data 
Markets 
AI
